Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Citi
Merck
Chinese Patent Office
Harvard Business School
McKesson
US Army
Argus Health
Farmers Insurance

Generated: April 27, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,599,552

« Back to Dashboard

Summary for Patent: 5,599,552
Title: Biodegradable polymer composition
Abstract:The invention is directed to a composition composed of a thermoplastic or thermosetting polymer which is capable of forming a biodegradable and/or bioerodible microporous, solid or gelatinous polymer matrix. The matrix is useful as an implant in animals for enhancing regeneration of cells and tissue, such as bone and nerve cells, or for delivery of biologically-active substances to tissue or organs. The composition is administered to an implant site as a liquid. The invention also includes a method of preventing and treating disorders and diseases, such as bone or nerve growth disorders, or of altering body functions such as birth control, using the compositions and implants of the invention.
Inventor(s): Dunn; Richard L. (Fort Collins, CO), Tipton; Arthur J. (Fort Collins, CO), Southard; George L. (Fort Collins, CO), Rogers; Jack A. (Fort Collins, CO)
Assignee: Atrix Laboratories, Inc. (Fort Collins, CO)
Application Number:08/249,630
Patent Claim Types:
see list of patent claims
Composition; Formulation; Device; Use;

Drugs Protected by US Patent 5,599,552

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 5,599,552

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 653498 ➤ Try a Free Trial
Australia 666676 ➤ Try a Free Trial
Australia 2605492 ➤ Try a Free Trial
Australia 6614294 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
McKinsey
Express Scripts
Cantor Fitzgerald
Deloitte
AstraZeneca
Accenture
US Department of Justice
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.